The Alliance of Community Health Plans (ACHP) has submitted a comment letter about the U.S. Patent and Trademark’s Office (USPTO) initiatives to ensure the robustness and reliability of patent rights. In the letter, ACHP urges USPTO to consider several reforms to address the high cost of drugs.
New from ACHP:
- ACHP Letter to Dr. Oz on Improving Partnership Between Regional Health Plans, CMS and Maximus
- ACHP Letter on Recommendations for Anticompetitive Regulations Task Force
- ACHP Statement on the Release of the MAHA Commission Report on Childhood Chronic Disease
- ACHP Statement on Increasing Risk Adjustment Audits in Medicare Advantage
- ACHP Statement on House Bill Threatening Medicaid Access and Marketplace Stability
- ACHP Letter to Office of Management and Budget Director Vought on Deregulation in Health Care
